TTS PHARMA LIMITED - Profile & Financials

Accounts Submitted 25 Sept 2025

Confirmation Statement Submitted 28 Sept 2025

Net assets £594.91K £593.90K 2024 year on year

Total assets £2.69M £154.45K 2024 year on year

Total Liabilities £2.10M £432.92K 2024 year on year

Charges 1

1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Liverpool Science Park 131 Mount Pleasant Liverpool L3 5TF

Office ()

Liverpool, Liverpool, United Kingdom, Europe

Telephone

447875210959

Website

ttspharma.com

Credit Report

Discover TTS PHARMA LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£2.67k

Decreased by £160.02k (-98%)

Net Assets

£594.91k

Decreased by £593.90k (-50%)

Total Liabilities

£2.10M

Increased by £432.92k (+26%)

Turnover

N/A

Employees

Debt Ratio

78%

Increased by 20 (+34%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£31k awarded

Show:

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

11 Allotments 73,733,562 Shares £3.46m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
2 Sept 2025	ORDINARY	3,232,810	£300k	£0.093
2 Sept 2025	ORDINARY	3,232,810	£300k	£0.093
2 Sept 2025	ORDINARY	3,232,810	£300k	£0.093
17 May 2023	ORDINARY	13,333,334	£400k	£0.03
12 Dec 2022	ORDINARY	16,666,667	£500k	£0.03

Officers

2 active 9 resigned

Show resigned officers

						Status
Paul Richard Atherton	Director	British	Jersey	60	13 Mar 2019	Active
Wilson Cecil Blaney	Director	British	United Kingdom	53	17 Nov 2022	Active

Shareholders

Shareholders (39)


Yanhui Ma	0.0%	17,692	Ordinary	6 Oct 2023
Wendy Susan Langley	0.0%	14,170	Ordinary	6 Oct 2023
Wang Tieguo	0.0%	13,638	Ordinary	6 Oct 2023

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Paul Richard Atherton

British

Active

Notified 13 Mar 2019

Residence United Kingdom

DOB May 1965

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

TTS PHARMA LIMITED Current Company

ENDOPURE LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ENDOPURE MEDICAL LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

MEDISONAL LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

THREE ISLES TRADING LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

TTS MANUFACTURING LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

1 satisfied

Documents

Company Filings

Date	Category	Description	Document
30 Sept 2025	Address	Change Sail Address Company With Old Address New Address	View(1 page)
28 Sept 2025	Capital	Allotment of shares (GBP 6,788.9) on 2025-09-02	View(3 pages)
28 Sept 2025	Capital	Allotment of shares (GBP 67,899.007) on 2025-09-02	View(3 pages)
28 Sept 2025	Capital	Allotment of shares (GBP 6,465.6197) on 2025-09-02	View(3 pages)
28 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-28 with no updates	View(3 pages)